November 17, 2016 - By Nellie Frank · 0 Comments
Nov 17 is a positive day so far for VanEck Vectors Generic Drugs ETF (NASDAQ:GNRX) as the ETF is active during the day after gaining 1.17% to hit $22.25 per share. The exchange traded fund has 2.20 million net assets and 1.33% volatility this month.
Over the course of the day 2,440 shares traded hands, as compared to an average volume of 1,490 over the last 30 days for VanEck Vectors Generic Drugs ETF (NASDAQ:GNRX).
The ETF is -13.90% of its 52-Week High and 2.39% of its low, and is currently having ATR of 0.4. This year’s performance is -11.26% while this quarter’s performance is -13.33%.
The ETF’s YTD performance is 0%, the 1 year is 0% and the 3 year is 0%.
More notable recent VanEck Vectors Generic Drugs ETF (NASDAQ:GNRX) news were published by: Etfdailynews.com which released: “This Generic Drug ETF Deserves Consideration Amid Biotech Weakness” on October 05, 2016, also Marketwatch.com with their article: “Generic-drug maker ETF could outperform biotech peers under Clinton” published on November 08, 2016, Businesswire.com published: “Van Eck Launches Market Vectors® Generic Drugs ETF (GNRX)” on January 13, 2016. More interesting news about VanEck Vectors Generic Drugs ETF (NASDAQ:GNRX) were released by: Marketwatch.com and their article: “VanEck Vectors Generic Drugs ETF” published on January 13, 2016 as well as Thestreet.com‘s news article titled: “Generic Drug ETF Can Dodge Biotech Smackdowns” with publication date: February 12, 2016.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Nellie Frank